Rafferty Asset Management’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-45,902
| Closed | -$6.94M | – | 1181 |
|
|
2022
Q3 | $6.94M | Buy |
45,902
+19,423
| +73% | +$2.94M | 0.07% | 227 |
|
|
2022
Q2 | $3.86M | Sell |
26,479
-18,522
| -41% | -$2.7M | 0.04% | 337 |
|
|
2022
Q1 | $5.34M | Sell |
45,001
-7,875
| -15% | -$934K | 0.03% | 375 |
|
|
2021
Q4 | $7.29M | Buy |
52,876
+29,720
| +128% | +$4.1M | 0.04% | 257 |
|
|
2021
Q3 | $3.22M | Sell |
23,156
-1,681
| -7% | -$234K | 0.02% | 438 |
|
|
2021
Q2 | $2.41M | Sell |
24,837
-16,031
| -39% | -$1.56M | 0.02% | 623 |
|
|
2021
Q1 | $2.79M | Buy |
40,868
+30,188
| +283% | +$2.06M | 0.02% | 533 |
|
|
2020
Q4 | $915K | Sell |
10,680
-22,928
| -68% | -$1.96M | 0.01% | 528 |
|
|
2020
Q3 | $2.19M | Buy |
33,608
+19,137
| +132% | +$1.24M | 0.03% | 391 |
|
|
2020
Q2 | $1.06M | Buy |
14,471
+7,631
| +112% | +$558K | 0.01% | 530 |
|
|
2020
Q1 | $233K | Sell |
6,840
-51,203
| -88% | -$1.74M | 0.01% | 490 |
|
|
2019
Q4 | $3.16M | Sell |
58,043
-67,735
| -54% | -$3.69M | 0.05% | 212 |
|
|
2019
Q3 | $5.25M | Buy |
125,778
+48,518
| +63% | +$2.02M | 0.08% | 148 |
|
|
2019
Q2 | $3.38M | Buy |
77,260
+20,951
| +37% | +$917K | 0.06% | 240 |
|
|
2019
Q1 | $2.9M | Buy |
+56,309
| New | +$2.9M | 0.05% | 230 |
|